15951830|t|Effect of oral administration of zanapezil (TAK-147) for 21 days on acetylcholine and monoamines levels in the ventral hippocampus of freely moving rats.
15951830|a|Zanapezil (TAK-147 (3-[1benzylpiperdin-4-yl]-1-(2,3,4,5-tetrahydro-1 H-1-benzazepin-8-yl) propan-1-one fumarate)) is a selective acetylcholine (ACh) esterase inhibitor under investigation as a drug for Alzheimer's disease (AD) treatment. In this study, the effects of TAK-147 at 2 mg kg(-1) p.o. for 21 days, compared to donepezil (E2020), on the levels of ACh, catecolamines and indoleamines were investigated in the ventral hippocampus (VH) of freely moving rats by microdialysis-high-performance liquid chromatography. The results revealed that the VH contains 92.05+/-21.97 fmol 20 microl(-1) ACh and the following monoamines levels (pg 30 microl(-1)), norepinephrine (NE) 1.92+/-0.39, epinephrine (Epi) 1.91+/-0.183, 3-methoxy-4-hydroxyphenylglycol (MHPG) 11.53+/-3.22, normetanephrine 3.26+/-0.61, dopamine (DA) 0.77+/-0.23, 3,4-dihydroxyphenylacetic acid (DOPAC) 3.37+/-1.01, homovanillic acid (4-hydroxy-3-methoxyphenylacetic acid; HVA) 4.04+/-0.93, 3-methoxytyramine 0.64+/-0.13, serotonin (5-HT) 0.73+/-0.16 and 5-hydroxyindoleacetic acid (5-HIAA) 313.15+/-18.42. On the 21st day and prior to the last dose, TAK-147 increased ACh, Epi, DA and 5-HT, whereas E2020 increased MHPG, Epi and DA. Following the last dose, TAK-147 increased NE, whereas E2020 increased NE, ACh and 5-HT in addition to their effects prior to the last dose. TAK-147 decreased HVA : DA ratio, but only marginally decreased DOPAC : DA and 5-HIAA : 5-HT ratios. On the other hand, E2020 decreased ratios of HVA : DA, DOPAC : DA (prior to the last dose), and 5-HIAA : 5-HT (90-180 min after the last dose). Both drugs decreased MHPG : NE only at 180 min after the last dose. The results also showed that TAK-147 increased Epi : NE ratio prior to and for 120 min following the last dose, whereas E2020 increased the ratio only before the last dose. The present results show that TAK-147 at a subthreshold dose could differentially increase ACh and 5-HT, compared to MHPG increased by E2020. The last dose of each drug could extend their effects to other monoamines. The increase of the monoamines levels, in addition to that on the ACh, and decrease of their oxidation could be of value in the treatment of the AD, other dementic diseases and the cohort neurological disorders depending on the type of the monoamine underlying the disorder.
15951830	33	42	zanapezil	Chemical	-
15951830	44	51	TAK-147	Chemical	MESH:C099872
15951830	68	81	acetylcholine	Chemical	MESH:D000109
15951830	86	96	monoamines	Chemical	-
15951830	148	152	rats	Species	10116
15951830	154	163	Zanapezil	Chemical	-
15951830	165	172	TAK-147	Chemical	MESH:C099872
15951830	174	265	3-[1benzylpiperdin-4-yl]-1-(2,3,4,5-tetrahydro-1 H-1-benzazepin-8-yl) propan-1-one fumarate	Chemical	-
15951830	356	375	Alzheimer's disease	Disease	MESH:D000544
15951830	377	379	AD	Disease	MESH:D000544
15951830	422	429	TAK-147	Chemical	MESH:C099872
15951830	475	484	donepezil	Chemical	MESH:D000077265
15951830	486	491	E2020	Chemical	MESH:D000077265
15951830	516	529	catecolamines	Chemical	-
15951830	534	546	indoleamines	Chemical	-
15951830	614	618	rats	Species	10116
15951830	773	783	monoamines	Chemical	-
15951830	811	825	norepinephrine	Chemical	MESH:D009638
15951830	844	855	epinephrine	Chemical	MESH:D004837
15951830	857	860	Epi	Chemical	MESH:D004837
15951830	876	907	3-methoxy-4-hydroxyphenylglycol	Chemical	MESH:D008734
15951830	909	913	MHPG	Chemical	MESH:D008734
15951830	929	944	normetanephrine	Chemical	MESH:D009647
15951830	958	966	dopamine	Chemical	MESH:D004298
15951830	968	970	DA	Chemical	MESH:D004298
15951830	985	1015	3,4-dihydroxyphenylacetic acid	Chemical	MESH:D015102
15951830	1017	1022	DOPAC	Chemical	MESH:D015102
15951830	1037	1054	homovanillic acid	Chemical	MESH:D006719
15951830	1056	1092	4-hydroxy-3-methoxyphenylacetic acid	Chemical	MESH:D006719
15951830	1094	1097	HVA	Chemical	MESH:D006719
15951830	1112	1129	3-methoxytyramine	Chemical	MESH:C001746
15951830	1143	1152	serotonin	Chemical	MESH:D012701
15951830	1154	1158	5-HT	Chemical	MESH:D012701
15951830	1176	1202	5-hydroxyindoleacetic acid	Chemical	MESH:D006897
15951830	1204	1210	5-HIAA	Chemical	MESH:D006897
15951830	1272	1279	TAK-147	Chemical	MESH:C099872
15951830	1295	1298	Epi	Chemical	MESH:D004837
15951830	1300	1302	DA	Chemical	MESH:D004298
15951830	1307	1311	5-HT	Chemical	MESH:D012701
15951830	1321	1326	E2020	Chemical	MESH:D000077265
15951830	1337	1341	MHPG	Chemical	MESH:D008734
15951830	1343	1346	Epi	Chemical	MESH:D004837
15951830	1351	1353	DA	Chemical	MESH:D004298
15951830	1380	1387	TAK-147	Chemical	MESH:C099872
15951830	1410	1415	E2020	Chemical	MESH:D000077265
15951830	1438	1442	5-HT	Chemical	MESH:D012701
15951830	1496	1503	TAK-147	Chemical	MESH:C099872
15951830	1514	1517	HVA	Chemical	MESH:D006719
15951830	1520	1522	DA	Chemical	MESH:D004298
15951830	1560	1565	DOPAC	Chemical	MESH:D015102
15951830	1568	1570	DA	Chemical	MESH:D004298
15951830	1575	1581	5-HIAA	Chemical	MESH:D006897
15951830	1584	1588	5-HT	Chemical	MESH:D012701
15951830	1616	1621	E2020	Chemical	MESH:D000077265
15951830	1642	1645	HVA	Chemical	MESH:D006719
15951830	1648	1650	DA	Chemical	MESH:D004298
15951830	1652	1657	DOPAC	Chemical	MESH:D015102
15951830	1660	1662	DA	Chemical	MESH:D004298
15951830	1693	1699	5-HIAA	Chemical	MESH:D006897
15951830	1702	1706	5-HT	Chemical	MESH:D012701
15951830	1762	1766	MHPG	Chemical	MESH:D008734
15951830	1838	1845	TAK-147	Chemical	MESH:C099872
15951830	1856	1859	Epi	Chemical	MESH:D004837
15951830	1929	1934	E2020	Chemical	MESH:D000077265
15951830	2012	2019	TAK-147	Chemical	MESH:C099872
15951830	2081	2085	5-HT	Chemical	MESH:D012701
15951830	2099	2103	MHPG	Chemical	MESH:D008734
15951830	2117	2122	E2020	Chemical	MESH:D000077265
15951830	2187	2197	monoamines	Chemical	-
15951830	2219	2229	monoamines	Chemical	-
15951830	2344	2346	AD	Disease	MESH:D000544
15951830	2354	2371	dementic diseases	Disease	MESH:D004194
15951830	2387	2409	neurological disorders	Disease	MESH:D009461
15951830	2439	2448	monoamine	Chemical	-
15951830	Positive_Correlation	MESH:C099872	MESH:D012701
15951830	Negative_Correlation	MESH:C099872	MESH:D000544
15951830	Positive_Correlation	MESH:C099872	MESH:D008734
15951830	Positive_Correlation	MESH:C099872	MESH:D006897
15951830	Positive_Correlation	MESH:C099872	MESH:D004837
15951830	Comparison	MESH:C099872	MESH:D000077265
15951830	Positive_Correlation	MESH:C099872	MESH:D004298
15951830	Positive_Correlation	MESH:C099872	MESH:D015102

